• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • +1-757-224-0177
  • 400-860-0210
  • fdahelpdesk
  • 联系我们
  • MyFDA登录
  • COVID-19 个人防护设备
  • 中文
    • English
    • Español
    • Italiano
    • Deutsch
    • Français
    • Portuguese
    • 日本語
Registrar

Registrar

Assistance with U.S. FDA Regulations

  • 中文
    • English
    • Español
    • Italiano
    • Deutsch
    • Français
    • Portuguese
    • 日本語
  • 向FDA注册
  • 服务
    • 向FDA注册
    • 化妝品FDA註冊
    • 认证及合规培训
    • 食品安全计划和FSMA
    • FDA标签
    • UDI与GUDID
    • 主文件
    • TTB Registration
  • 行业
    • 食品和饮料
    • 膳食补充剂
    • 医疗器械
    • 药品
    • 化妆品
    • 其它
  • 资源
    • 资源
    • 新闻
    • 商业活动/研讨会
    • 工具类
  • 关于我们
    • 关于我们
    • 联系我们

Guide to U.S. Wine Label Regulations

Guide to U.S. Wine Label Regulations

The Alcohol and Tobacco Tax and Trade Bureau (TTB) regulates wine with an alcohol content of 7% or more, and the labeling of these wines must be approved by TTB before marketing.  Registrar Corp’s wine labeling guide will arm you with the knowledge you need to develop a compliant wine label.

Our guide contains information on:

  • Class and Type Designations – Understand requirements for identifying your wine as a certain class (grape, citrus, etc.) and type (table, dessert, red, white, Chianti, etc.)
  • Required Content – Ensure your wine label includes all necessary components (origin, alcohol content, net contents, etc.)
  • Sizing and Placement – TTB requires a particular type size and placement of everything from the brand name to health warnings.
  • Disclosures – Certain contents must be disclosed on the label (sulfites, allergens, some color additives, etc.)

Complete the form below and receive a copy of our wine labeling guide for only $195 USD:

Click here to download a preview of the guide.

1Company Information
2Payment Information
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • 应支付费用

  • 应支付费用
    总计
  • Bill to:

  • Price: $695.00
  • This field is hidden when viewing the form
  • (Valid until December 31,  )
  • (有效期至 年12月31日)
  • (有效期至 年12月31日)
  • (有效期至)
    包括FDA合规监控和出货监控
  • Based on your specified suppliers, Registrar Corp recommends a block of . This value can be changed below.

  • (valid until )
  • (valid until )
  • This field is hidden when viewing the form
  • Registrar Corp recommends having the following documents for this submission:

    For the product:

    • Product name, number and size of retail containers, batch and lot numbers, any product identification codes, IFN number (if previously notified to FDA)
    • Countries in which currently marketed and duration
    • Quantity intended to be introduced to US market (by weight).
    • “Use by” date if in current inventory. If not in current inventory, the date you plan to introduce it into U.S. commerce. Indicate if it will be a one-time shipment or multiple shipments.
    • Name and location of manufacturing facilities
    • Distribution plan down to retail level, if available
    • Full quantitative formulation, list of all ingredients, amount of each ingredient per absolute amount (such as mg/kg or g/L)
    • Copy of the product label
    • Description of the product packaging
    • Summary of finished product testing results for most recent batch/lot at each facility:
      • Level of each nutrient required by 21 CFR 107.100
      • Level of any other nutrient added by the manufacturer in units per 100 kcal
      • Explanation of any deviation for a specialized formula that may not meet all requirements but is appropriate for dietary management of a specific disease or disorder
    • For powdered formula, a summary of finished product testing results for the most recent batch/lot at each facility:
      • For Cronobacter : 30 samples, with each sample being 10 grams
      • For Salmonella : 60 samples, with each sample being 25 grams
      • Description of test method used and copy of the method (e.g., certificate of
        analysis with information listed in 21 CFR 117.165(b)(2) from a qualified laboratory)

    For each manufacturing facility:

    • Certification of established current GMP designed to prevent adulteration, including quality control procedures and in-process controls, and testing required under the cGMP
    • Schematic diagram (i.e. process flow diagram) with processing times and temperatures, written narrative that includes a summary of process flow, heating and processing conditions, and critical control points
    • FDA Food Facility Registration Number
    • If facility has not received an FDA inspection:
      • Date of last inspection by the relevant government authority, or
      • Third party audit conducted by a qualified auditor on behalf of the government authority
      • Summary of the findings, standards/regulations against which the inspection was conducted, and any actions taken by the manufacturer in response
  • $0.00
  • please wait
  • American Express
    Discover
    MasterCard
    Visa
    Supported Credit Cards: American Express, Discover, MasterCard, Visa
     
  • This field is hidden when viewing the form
    MM slash DD slash YYYY

Primary Sidebar

联系我们

 

Registrar Corp总部

Room 606-608, Block A, Rongchao Binhai

Building, No. 5

Xinghua 1st Road, Bao’an CBD

Shenzhen City, People’s Republic of China

 

400-860-0210

 

(+86)-755-82070866

 

[email protected]

 
 
 
 

查看我们的位置

24/7在线帮助

我们的方案

向FDA注册

FDA Compliance Monitor

FDA标签

查看全部

关于我们

关于我们

资源

工具

费用

联系我们

 

评论

地址

商业活动

协会

电话: +1-757-224-0177

传真: +1-757-224-0179

[email protected]

© 2026 Registrar Corp

144 Research Drive Hampton, Virginia 23666 USA
使用条款 | 隐私条例

  • 中文
    • English
    • Español
    • Italiano
    • Deutsch
    • Français
    • Portuguese
    • 日本語
    • Back
  • 向FDA注册
  • 服务
    • 向FDA注册
    • 化妝品FDA註冊
    • 认证及合规培训
    • 食品安全计划和FSMA
    • FDA标签
    • UDI与GUDID
    • 主文件
    • TTB Registration
    • Back
  • 行业
    • 食品和饮料
    • 膳食补充剂
    • 医疗器械
    • 药品
    • 化妆品
    • 其它
    • Back
  • 资源
    • 资源
    • 新闻
    • 商业活动/研讨会
    • 工具类
    • Back
  • 关于我们
    • 关于我们
    • 联系我们
    • Back

通知:未能完成 年FDA注册续期的企业必须重新注册

通知: 未能完成 年医疗器械FDA注册和药品FDA注册续期的企业必须重新注册

立即重新注册

已持有FDA注册的企业必须在 年12月31日前延续其注册

医疗器械注册和药品注册必须在 年12月31日前完成注册续期

立即续期

提醒

美国食品药品管理局(FDA)要求所有食品、药品、 医疗器械注册企业在 年10月1日到12月31日期间延续其注册。

立即续期

通知

美国FDA注册延续时间将在年12月31日截至

若您未能在截止日前完成续期,将需要重新注册。

重新注册或者验证您的注册是否已延续至:

重新注册
验证

限时特惠

即日注册,即可用一年的费用享受18个月的注册和代理人服务有效期

Get Started